{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:08:07Z","timestamp":1791893287106,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007698","name":"University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007698","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ejmech.2018.01.033","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T08:25:31Z","timestamp":1515745531000},"page":"47-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII"],"prefix":"10.1016","volume":"146","author":[{"given":"Alessandro","family":"Bonardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Falsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8821-928X","authenticated-orcid":false,"given":"Daniela","family":"Catarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4342-9427","authenticated-orcid":false,"given":"Flavia","family":"Varano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Di Cesare Mannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Tenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ghelardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9296-6819","authenticated-orcid":false,"given":"Vittoria","family":"Colotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.01.033_bib1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumors as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.01.033_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.033_bib3","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.3390\/metabo7030048","article-title":"Carbonic anhydrase inhibition and the management of hypoxic tumors","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.ejmech.2018.01.033_bib4","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fphys.2013.00400","article-title":"Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors","volume":"4","author":"Sedlakova","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejmech.2018.01.033_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11307-015-0885-x","article-title":"Evaluation of CA IX and CA XII expression in breast cancer at varied O2 levels: CA IX is the superior surrogate imaging biomarker of tumor hypoxia","volume":"18","author":"Tafreshi","year":"2016","journal-title":"Mol. Imag. Biol."},{"key":"10.1016\/j.ejmech.2018.01.033_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.semcancer.2017.01.005","article-title":"Out of Warburg effect: an effective cancer treatment targeting the tumor specific metabolism and dysregulated pH","volume":"43","author":"Schwartz","year":"2017","journal-title":"Semin. Canc. Biol."},{"key":"10.1016\/j.ejmech.2018.01.033_bib7","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.bbamem.2014.10.015","article-title":"Proton channels and exchangers in cancer","volume":"1848","author":"Spugnini","year":"2015","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejmech.2018.01.033_bib8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2013.798648","article-title":"Anticancer carbonic anhydrase inhibitors: a patent review (2008\u20132013)","volume":"23","author":"Monti","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2018.01.033_bib9","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10555-014-9531-3","article-title":"Microenvironmental acidosis in carcinogenesis and metastases; new strategies in prevention and therapy","volume":"33","author":"Fais","year":"2014","journal-title":"Canc. Metastasis Rev."},{"key":"10.1016\/j.ejmech.2018.01.033_bib10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/cam4.991","article-title":"Hypoxia-inducible factor promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression","volume":"6","author":"Sowa","year":"2017","journal-title":"Cancer Med."},{"key":"10.1016\/j.ejmech.2018.01.033_bib11","doi-asserted-by":"crossref","first-page":"8371","DOI":"10.1039\/c0cc02707c","article-title":"Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency","volume":"44","author":"Pacchiano","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2018.01.033_bib12","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2018.01.033_bib13","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1021\/acs.jmedchem.5b00523","article-title":"6-Substituted sulfocoumarins are selective carbonic anhydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells","volume":"58","author":"Grandane","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.033_bib14","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1039\/c2cc34275h","article-title":"Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors","volume":"48","author":"Maresca","year":"2012","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2018.01.033_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1021\/jm400902y","article-title":"Design, synthesis, and evaluation of hydroxamic acid derivatives as promising agents for the management of chagas disease","volume":"57","author":"Capaci Rodrigues","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.033_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/jm901287j","article-title":"Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins","volume":"53","author":"Maresca","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.033_bib17","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/ja809683v","article-title":"Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors","volume":"131","author":"Maresca","year":"2009","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.01.033_bib18","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1016\/j.bmc.2013.05.032","article-title":"7-Substituted-sulfocoumarins are isoform-selective, potent carbonic anhydrase II inhibitors","volume":"21","author":"Tanc","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.033_bib19","first-page":"345","article-title":"Synthesis, biological activity and multiscale molecular modeling studies for coumarylcarboxamide derivatives as selective carbonic anhydrase IX inhibitors","volume":"31","author":"Kurt","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.033_bib20","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1021\/acs.jmedchem.6b01607","article-title":"Design and synthesis of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids (NSAIDs\u2212CAIs) for the treatment of rheumatoid arthritis","volume":"60","author":"Bua","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.033_bib21","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.1021\/acs.jmedchem.7b00766","article-title":"3-Hydroxy-1H-quinazoline-2,4-dione as a new scaffold to develop potent and selective inhibitors of the tumor-associated carbonic anhydrases IX and XII","volume":"60","author":"Falsini","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.033_bib22","doi-asserted-by":"crossref","first-page":"14882","DOI":"10.3390\/molecules171214882","article-title":"Synthesis and in\u00a0vitro antioxidant activity evaluation of 3-carboxycoumarin derivatives and QSAR study of their DPPH\u2022 radical scavenging activity","volume":"17","author":"Mart\u00ednez-Mart\u00ednez","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.01.033_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/jm00396a001","article-title":"Synthesis, binding studies and structure-activity relationships of 1-aryl and 2-aryl[1]benzopyrano-pyrazole-4-ones, central benzodiazepine receptor ligands","volume":"31","author":"Colotta","year":"1988","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.033_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jps.2600780314","article-title":"Tricyclic heteroaromatic systems. Synthesis, [3H]-flunitrazepam brain membranes binding inhibition and structure-activity relationships of 2,3-dihydro-2-aryl-4-R-[1]benzopyrano[4,3-c]pyrazole-3-ones","volume":"78","author":"Colotta","year":"1989","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2018.01.033_bib25","first-page":"111","article-title":"Novel adenosine receptor ligands: 1,3-disubstituted[1]benzopyrano[2,3-c]pyrazol-4-ones. Synthesis and structure-activity relationships","volume":"1","author":"Colotta","year":"1993","journal-title":"Recept. Channel"},{"key":"10.1016\/j.ejmech.2018.01.033_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ejmech.2013.03.042","article-title":"Synthesis, anticancer activity and photophysical properties of novel substituted 2-oxo-2H-chromenylpyrazolecarboxylates","volume":"65","author":"Kumar","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.033_bib27","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1023\/B:COHC.0000018338.41222.a2","article-title":"Reactions of 4-chloro-3-formylcoumarin with arylhydrazines","volume":"39","author":"Strakova","year":"2003","journal-title":"Chem. Heterocycl. Comp."},{"key":"10.1016\/j.ejmech.2018.01.033_bib28","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1246\/bcsj.60.4425","article-title":"Synthesis of pyrano[4,3-c]pyrazol-4(1H)-ones and 4-(2H)-ones from dehydroacetic acid. Homo- and heteronuclear selective NOE measurements for unambiguous structure assignment","volume":"60","author":"Cantos","year":"1987","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.ejmech.2018.01.033_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejmech.2012.01.042","article-title":"Design, synthesis, computational and biological evaluation of some new hydrazine derivatives of DHA and pyranopyrazoles derivatives of DHA and pyranopyrazoles","volume":"50","author":"Kumar","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.033_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.15227\/orgsyn.029.0054","article-title":"Indazole","volume":"29","author":"Stephenson","year":"1949","journal-title":"Org. Synth."},{"key":"10.1016\/j.ejmech.2018.01.033_bib31","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/acsmedchemlett.7b00280","article-title":"Discovery of new selenoureido analogues of 4-(4-fluorophenylureido)benzenesulfonamide as carbonic anhydrase inhibitors","volume":"8","author":"Angeli","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.01.033_bib32","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.01.033_bib33","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/acs.jmedchem.5b01720","article-title":"Thioxocoumarins show an alternative carbonic anhydrase inhibition mechanism compared to coumarins","volume":"59","author":"Ferraroni","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.033_bib34","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1021\/jm9901879","article-title":"Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl\/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route","volume":"42","author":"Scozzafava","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.033_bib35","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.bmc.2015.02.027","article-title":"A\u00a0class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects","volume":"23","author":"Carta","year":"2015","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418300461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418300461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T10:01:29Z","timestamp":1660298489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418300461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":35,"alternative-id":["S0223523418300461"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.033","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}